Protein Kinase C Promotes Notch1 Cleavage Through Both Ligand-Dependent and Hyaluronic Acid-ADAM10-Dependent

Xin Tang1,2,3,4, Yunfei Mu2,3,4, Hongjun Shi2,3,4

  • 1College of Life Sciences, Zhejiang University, Hangzhou 310058, China.

Cells
|August 13, 2026
PubMed

Insights

Protein kinase C (PKC) activates Notch1 signaling in endothelial cells through two pathways: upregulating Notch ligands and promoting hyaluronan synthesis. This reveals the extracellular matrix as a key regulator of Notch1 signal strength.

Area of Science:

  • Endothelial cell biology
  • Molecular signaling pathways
  • Extracellular matrix interactions

Background:

  • Notch1 signaling is crucial for vascular development and endothelial cell fate.
  • Protein kinase C (PKC) is known to activate Notch1, but the precise mechanisms are unclear.

Purpose of the Study:

  • To elucidate the molecular mechanisms by which PKC activates Notch1 signaling in endothelial cells.
  • To identify the role of extracellular matrix components in PKC-mediated Notch1 activation.

Main Methods:

  • Utilized murine endothelial MS1 cells and mouse aortic endothelial cells (MAECs).
  • Investigated the effects of PKC activation on Notch1 ligands (Jag1, Dll4), hyaluronic acid synthase 2 (HAS2), and hyaluronan (HA) synthesis.
  • Employed genetic (knockdown/overexpression) and pharmacological (4-MU) approaches to assess the role of HA.
  • Examined ADAM10 localization and Notch1 phosphorylation.

Main Results:

  • PKC activation upregulates Jag1 and Dll4, creating a positive feedback loop for Notch signaling.
  • PKC enhances HAS2 expression, leading to increased hyaluronan (HA) synthesis, which is essential for Notch1 activation.
  • HA signaling is required for PKC to activate Notch1, and its inhibition downregulates cell surface ADAM10.
  • Direct phosphorylation of Notch1 at S1791 is not required for PKC-mediated activation.

Conclusions:

  • PKC employs a dual pathway involving ligand upregulation and HA signaling to promote Notch1 proteolytic cleavage.
  • The extracellular matrix, specifically HA, acts as a critical regulator of Notch1 signal strength in endothelial cells.
  • These findings uncover a novel mechanism linking PKC, extracellular matrix, and Notch1 signaling in vascular biology.

Related Concept Videos

Notch Signaling Pathway03:14

Notch Signaling Pathway

The Notch signaling pathway is a major intracellular signaling pathway that is highly conserved over a broad spectrum of metazoan species. It stands unique from other intracellular signaling mechanisms in animals because notch protein itself acts as the receptor as well as the primary signaling molecule.
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Non-Canonical Wnt Signaling Pathways01:41

Non-Canonical Wnt Signaling Pathways

Wnt is a zygotic effect gene that is expressed during very early embryonic development. It regulates various processes in animals starting from early development through the adult stage, such as organogenesis in the embryo and maintenance of neuronal and blood stem cells. Wnt proteins can induce a wide variety of intracellular pathways depending upon the specific abilities of different Wnt ligands to form a complex with shared and cognate receptors in the presence of different co-receptors. The...